Integral Ad Science Holding Corp. (NASDAQ:IAS) Short Interest Up 8.2% in June

Integral Ad Science Holding Corp. (NASDAQ:IAS) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 6,860,000 shares, an increase of 8.2% from the May 31st total of 6,340,000 shares. Currently, 9.6% of the company’s stock are short sold. Based on an average daily volume of 1,900,000 shares, the days-to-cover ratio is presently 3.6 days.

Integral Ad Science Stock Performance

NASDAQ:IAS traded down $0.09 during mid-day trading on Wednesday, hitting $9.68. 420,719 shares of the company traded hands, compared to its average volume of 1,776,362. The stock’s fifty day moving average price is $9.54 and its 200-day moving average price is $11.69. Integral Ad Science has a one year low of $7.98 and a one year high of $20.88. The company has a quick ratio of 4.32, a current ratio of 4.32 and a debt-to-equity ratio of 0.13. The firm has a market cap of $1.55 billion, a price-to-earnings ratio of 968.00, a price-to-earnings-growth ratio of 1.69 and a beta of 1.54.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $114.50 million during the quarter, compared to analyst estimates of $112.12 million. Integral Ad Science had a return on equity of 0.32% and a net margin of 0.59%. Integral Ad Science’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.02 earnings per share. Research analysts anticipate that Integral Ad Science will post 0.22 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Lisa Utzschneider sold 30,407 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $305,590.35. Following the completion of the transaction, the chief executive officer now owns 188,678 shares in the company, valued at approximately $1,896,213.90. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Integral Ad Science news, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the completion of the transaction, the chief accounting officer now owns 145,550 shares in the company, valued at $1,323,049.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lisa Utzschneider sold 30,407 shares of Integral Ad Science stock in a transaction on Monday, April 8th. The shares were sold at an average price of $10.05, for a total value of $305,590.35. Following the transaction, the chief executive officer now owns 188,678 shares of the company’s stock, valued at approximately $1,896,213.90. The disclosure for this sale can be found here. Insiders sold a total of 59,875 shares of company stock worth $598,224 in the last quarter. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Integral Ad Science

A number of hedge funds have recently made changes to their positions in the business. Ameritas Investment Partners Inc. lifted its position in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after buying an additional 1,924 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of Integral Ad Science in the third quarter worth about $140,000. ProShare Advisors LLC purchased a new stake in shares of Integral Ad Science in the first quarter worth about $121,000. Vontobel Holding Ltd. purchased a new stake in shares of Integral Ad Science in the fourth quarter worth about $176,000. Finally, American Trust lifted its position in shares of Integral Ad Science by 10.8% in the third quarter. American Trust now owns 13,328 shares of the company’s stock worth $158,000 after buying an additional 1,302 shares in the last quarter. Institutional investors own 95.78% of the company’s stock.

Analysts Set New Price Targets

IAS has been the subject of several recent analyst reports. Raymond James decreased their price target on Integral Ad Science from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Friday, May 10th. Morgan Stanley restated an “equal weight” rating and issued a $12.00 price target (down previously from $18.00) on shares of Integral Ad Science in a research note on Tuesday, April 16th. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research note on Tuesday, May 7th. Barclays decreased their price target on Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Finally, Craig Hallum cut their price objective on Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a report on Friday, May 10th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Integral Ad Science has an average rating of “Moderate Buy” and an average price target of $16.77.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.